RA

Rajan Abishek

Active Director Director DIN 11087101
DIN 11087101 First appointment May 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since May 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Rajan Abishek

Data last updated:

Rajan Abishek is a Director at Arindiva Lifesciences Private Limited (since 2025) and Director at A2 Ambur Surgicals Private Limited (since 2025). The companies operate in Pharma.

DIN 11087101
Primary Designation Director
Industry Pharma
First Appointment 17 May 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director20 May 20252025Active
A2 Ambur Surgicals Private Limited U21003TN2025PTC180620
Director17 May 20252025Active

Board colleagues of Rajan Abishek

Directorship timeline

Open interactive timeline →
Arindiva Lifesciences Private Limited
A2 Ambur Surgicals Private Limited
Premium access

Shareholding and investment profile for Rajan Abishek

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajan Abishek

Rajan Abishek currently holds 2 directorships: Arindiva Lifesciences Private Limited (Director, since 20 May 2025); A2 Ambur Surgicals Private Limited (Director, since 17 May 2025).

Rajan Abishek was first appointed on 17 May 2025 as Director at A2 Ambur Surgicals Private Limited.

The current boards of Rajan Abishek's companies include Nivasan Rajan (Arindiva Lifesciences Private Limited), Issac Arulkumar (A2 Ambur Surgicals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available